SCHEMBL4616033

SCHEMBL4616033

O=S(=O)(F)c1cc(Cl)sc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.52
CDK1 P06493 3/20 0.46
CCNB1 P14635 3/20 0.46
CCNA2 P20248 3/20 0.46
CCND1 P24385 3/20 0.46
CDK2 P24941 3/20 0.46
CDK7 P50613 3/20 0.46
CCNH P51946 3/20 0.46
CCNA1 P78396 3/20 0.46
CDK6 Q00534 3/20 0.46
TDP1 Q9NUW8 1/20 0.42
S100A9 P06702 4/20 0.41
DAO P14920 1/20 0.39
PFKFB3 Q16875 1/20 0.39
APP P05067 1/20 0.39
ACLY P53396 1/20 0.36
GSK3B P49841 1/20 0.35
EPHX2 P34913 1/20 0.35
TYMS P04818 1/20 0.35
SGK1 O00141 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11057472 0.80 PKM (0.34) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL388032 0.79 PKM (0.53) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL12560498 0.77 PKM (0.52) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL301846 0.77 PKM (0.52) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL1645094 0.77 PKM (0.52) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL6038652 0.77 PKM (0.52) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL11760740 0.76 PKM (0.50) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL5137127 0.76 PKM (0.50) PKMCDK1CCNB1CCNA2CCND1
Potassium Ion SCHEMBL11757835 0.76 PKM (0.50) PKMCDK1CCNB1CCNA2CCND1
SCHEMBL11757841 0.76 PKM (0.50) PKMCDK1CCNB1CCNA2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN disclosed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 PKM 4493/4885CDK1 1947/4885CCNB1 2750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.